Addressing wholesale distributor barriers to buprenorphine access: Consensus recommendations from the PhARM-OUD expert panel
Objective: Less than one-in-four patients with opioid use disorder receive opioid agonist treatment. This is in part due to the fact that less than 60 % of pharmacies stock and dispense buprenorphine products for the treatment of opioid use disorder (OUD). Pharmacies do not stock for many reasons bu...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Drug and Alcohol Dependence Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772724625000435 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|